Neena M. Patil - 26 Feb 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Paz Dizon, as attorney in fact For: Neena Patil
Issuer symbol
JAZZ
Transactions as of
26 Feb 2026
Net transactions value
-$4,161,782
Form type
4
Filing time
02 Mar 2026, 17:06:54 UTC
Previous filing
21 Jan 2026
Next filing
09 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patil Neena M EVP & Chief Legal Officer 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Paz Dizon, as attorney in fact For: Neena Patil 02 Mar 2026 0001783908

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $2,276,138 +20,125 +38% $113.10 73,464 26 Feb 2026 Direct
transaction JAZZ Ordinary Shares Sale $3,196,335 -16,602 -23% $192.53 56,862 26 Feb 2026 Direct F1
transaction JAZZ Ordinary Shares Options Exercise $98,962 +875 +1.5% $113.10 57,737 26 Feb 2026 Direct
transaction JAZZ Ordinary Shares Sale $168,057 -875 -1.5% $192.07 56,862 26 Feb 2026 Direct F2
transaction JAZZ Ordinary Shares Options Exercise $3,713,758 +27,084 +48% $137.12 83,946 26 Feb 2026 Direct
transaction JAZZ Ordinary Shares Sale $2,959,807 -15,555 -19% $190.28 68,391 26 Feb 2026 Direct F3
transaction JAZZ Ordinary Shares Options Exercise $399,842 +2,916 +4.3% $137.12 71,307 26 Feb 2026 Direct
transaction JAZZ Ordinary Shares Sale $553,491 -2,916 -4.1% $189.81 68,391 26 Feb 2026 Direct F4
transaction JAZZ Ordinary Shares Award $0 +10,079 +15% $0.000000 78,470 26 Feb 2026 Direct F5
transaction JAZZ Ordinary Shares Sale $2,209,481 -11,529 -15% $191.65 66,941 26 Feb 2026 Direct F6
transaction JAZZ Ordinary Shares Sale $681,993 -3,523 -5.3% $193.58 63,418 26 Feb 2026 Direct F7
transaction JAZZ Ordinary Shares Sale $201,594 -1,061 -1.7% $190.00 62,357 26 Feb 2026 Direct F8
transaction JAZZ Ordinary Shares Sale $104,747 -549 -0.88% $190.80 61,808 26 Feb 2026 Direct F9
transaction JAZZ Ordinary Shares Sale $342,312 -1,784 -2.9% $191.88 60,024 26 Feb 2026 Direct F10
transaction JAZZ Ordinary Shares Sale $194,527 -1,009 -1.7% $192.79 59,015 26 Feb 2026 Direct F11
transaction JAZZ Ordinary Shares Sale $38,139 -197 -0.33% $193.60 58,818 26 Feb 2026 Direct F12

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Incentive Stock Option (right to buy) Options Exercise $0 -875 -100% $0.000000 0 26 Feb 2026 Ordinary Shares 875 $113.10 Direct F13
transaction JAZZ Incentive Stock Option (right to buy) Options Exercise $0 -2,916 -100% $0.000000 0 26 Feb 2026 Ordinary Shares 2,916 $137.12 Direct F14
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -20,125 -100% $0.000000 0 26 Feb 2026 Ordinary Shares 20,125 $113.10 Direct F13
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -27,084 -100% $0.000000 0 26 Feb 2026 Ordinary Shares 27,084 $137.12 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $192.1100 to $193.0100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F2 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $192.0600 to $192.1100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F3 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.9150 to $190.9000. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $189.7300 to $189.9150. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F6 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $191.3200 to $192.0600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F7 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $193.2900 to $193.8400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F8 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.395 to $190.3700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F9 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.4100 to $191.2150. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F10 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $191.4750 to $192.4300. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F11 Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $192.4600 to $193.4500. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F12 Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $193.5300 to $193.6700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F13 These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
F14 These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of July 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.